Thymosin ␣ 1 (T␣) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T
Effects of Qianlie’an suppository in patients with chronic prostatitis syndrome: A randomized open-labelled prospective and controlled trial
✍ Scribed by Xing Jun-ping; Chen Xing-fa; Yang Zhi-shang; Wang Ming-zhu; He Da-lin
- Publisher
- Chinese Association of Traditional and Western Medicine
- Year
- 2003
- Tongue
- English
- Weight
- 359 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1672-0415
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Ongoing hepatitis B virus replication in the presence of antibody to HBeAg can be observed in patients with active liver disease. These forms of chronic hepatitis B have been described as having a poor prognosis. We have conducted a randomized controlled trial to assess the efficacy of lymphoblastoi
## Background: We aimed to determine the effect of dietary counseling or oral supplements on outcome for patients with cancer, specifically, nutritional outcome, morbidity, and quality of life (qol), during and 3 months after radiotherapy. ## Methods: Seventy-five patients with head and neck canc